India Globalization Capital Inc

ASE:IGC  
0.59
-0.02 (-3.80%)
Mergers / Acquisitions

IGC Acquires Exclusive Rights For A Potential Alzheimer's Drug Development Candidate

Published: 06/21/2022 04:21 GMT
India Globalization Capital Inc (IGC) - Igc Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate.
Igc - Acquired Exclusive Global Rights to the Molecule and Plans to Develop This Nmi Lead Candidate Further.
Igc - Currently in Human Trials With Igc-ad1 That Targets Neuropsychiatric Symptoms Associated With Dementia in Alzheimer’s.